Related Experiment Video

Updated: Aug 11, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

Components of the IFN-gamma signaling pathway in tumorigenesis

George Blanck1

  • 1Department of Biochemistry and Molecular Biology, Moffitt Cancer Center, University of South Florida College of Medicine, MDC Box 7, 12901 Bruce B. Downs Blvd. MDC7, Tampa, FL 33612, USA. Gblanck@hsc.usf.edu

Archivum Immunologiae Et Therapiae Experimentalis
|July 9, 2002
PubMed

Insights

Interferon gamma (IFN-gamma) signaling has anti-tumor effects, promoting apoptosis and immune responses. However, its role in cancer is complex, not exclusively anti-tumorigenic, limiting current therapeutic applications.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • The interferon gamma (IFN-gamma) signaling pathway is recognized for its potential anti-tumorigenic properties.
  • This pathway can induce apoptosis and upregulate immune-related proteins, suggesting a role in tumor destruction.
  • Existing research generally supports the anti-tumorigenic hypothesis of IFN-gamma signaling.

Purpose of the Study:

  • To review the current understanding of the IFN-gamma signaling pathway in tumorigenesis.
  • To emphasize the pathway's role in MHC class II induction on tumor cells and apoptosis induction.
  • To identify future research directions for leveraging IFN-gamma knowledge in cancer therapy.

Main Methods:

  • Literature review of experimental approaches and existing data on IFN-gamma signaling in cancer.
  • Analysis of studies focusing on MHC class II expression and apoptosis induction by IFN-gamma.
  • Synthesis of current knowledge to identify therapeutic and prognostic gaps.

Main Results:

  • While generally anti-tumorigenic, the IFN-gamma pathway's role in cancer is more complex than initially thought.
  • Data suggest the pathway is not exclusively anti-tumorigenic, indicating context-dependent effects.
  • Limited translation of IFN-gamma pathway knowledge into effective cancer prognosis or therapy to date.

Conclusions:

  • The dual role of IFN-gamma in tumorigenesis necessitates a nuanced understanding.
  • Targeting IFN-gamma-mediated MHC class II and apoptosis induction holds potential for cancer treatment.
  • Further investigation is crucial to translate IFN-gamma pathway insights into reduced cancer mortality.

More Related Videos

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses10:10

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses

Published on: November 16, 2016

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...